Ask about a decision

Name what your team needs to evaluate or prepare for — an asset, indication, regulatory decision, guideline review, or coverage restriction. Add the date if you have one. We reply the same business day with confirmation of the question we would assess, or one follow-up question.

  1. 1 Your question
  2. 2 Context (optional)

What decision or asset are you evaluating?

The drug or class, indication, authority (e.g. NCCN, FDA, CMS), or milestone date. We help scope the exact question.

Or start from one of these:
Help me phrase it
Authority

A meeting, submission, transaction, planning window, or timing you're still deciding.

Work or personal.

Book a call instead

Evaluations run under mutual NDA. We work from published regulatory dockets, guidelines, and literature, so the question, and its date if you have one, is all we need to start.

Prefer direct contact? Reach founder Kanav Jain at kanav@nextconsensus.com.